title: Detection of adverse events: what are the current sensitivity limits during clinical development?
authors.affiliation: Wyeth-Lederle Vaccines, 80 rue du Président Charles De Gaule, 92031, Paris La Defense, France. Fritzeb@war.wyeth.com
authors.forename: B
authors.initials: B
authors.lastname: Fritzell
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D014612:Vaccines / Q000009:adverse effects*
chemical_list: D014612:Vaccines